Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

General Skin and Nasal Decolonization With Octenisan® Set Be-fore and After Elective Orthopedic Surgery in Selected Patients at Elevated Risk for Revision Surgery and Surgical Site Infections

NCT05647252 is registered in ClinicalTrials.gov with Balgrist University Hospital as lead sponsor.

NCT NCT05647252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05647252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
General Skin and Nasal Decolonization With Octenisan® Set Be-fore and After Elective Orthopedic Surgery in Selected Patients at Elevated Risk for Revision Surgery and Surgical Site Infections
Lead sponsor
Balgrist University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 27, 2023
Completion date
February 20, 2025
Enrollment
1,086 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

elective surgery, high risk, prevention of surgical site infections, randomized-controlled trial